Authors: Tkaczuk, J Milford, E Yu, C Baksh, S Carpenter, C Burakoff, S McKay, D

Citation: J. Tkaczuk et al., Intracellular signaling consequences of anti-IL-2R alpha blockade by daclizumab, TRANSPLAN P, 33(1-2), 2001, pp. 212-213

Authors: Baksh, S Friedman, J Burakoff, SJ Bierer, BE

Citation: S. Baksh et al., Immunosuppressants and immunophilin binding agents: Current research and clinical applications, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 81-102

Authors: Baksh, S Burakoff, SJ

Citation: S. Baksh et Sj. Burakoff, The role of calcineurin in lymphocyte activation, SEMIN IMMUN, 12(4), 2000, pp. 405-415

Authors: Baksh, S DeCaprio, JA Burakoff, SJ

Citation: S. Baksh et al., Calcineurin regulation of the mammalian G(0)/G(1) checkpoint element, cyclin dependent kinase 4, ONCOGENE, 19(24), 2000, pp. 2820-2827

Authors: Pratt, JC Igras, VE Maeda, H Baksh, S Gelfand, EW Burakoff, SJ Neel, BG Gu, HH

Citation: Jc. Pratt et al., Cutting edge: Gab2 mediates an inhibitory phosphatidylinositol 3 '-kinase pathway in T cell antigen receptor signaling, J IMMUNOL, 165(8), 2000, pp. 4158-4163